End-of-day quote
Other stock markets
|
||
- EUR | - |
05-10 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-13 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 |
Sales 2024 * | 349M 376M 29.61B | Sales 2025 * | 379M 409M 32.19B | Capitalization | 241M 260M 20.48B |
---|---|---|---|---|---|
Net income 2024 * | 11M 11.88M 934M | Net income 2025 * | 14M 15.12M 1.19B | EV / Sales 2024 * | 0.81 x |
Net Debt 2024 * | 39.5M 42.66M 3.36B | Net Debt 2025 * | 33.3M 35.96M 2.83B | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
17
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.21% |
Latest transcript on Laboratorio Reig Jofre SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 31/12/05 | |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/02 |
Chief Operating Officer | 52 | 31/12/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 31/12/05 | |
Director/Board Member | - | 30/12/14 | |
Director/Board Member | - | 30/12/14 |
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |